Brian C. Sauer, PhD, MS

Research Interests

  • Pharmacoepidemiology
  • Medical Informatics
  • Health Care Quality and Patient Safety
  • Quality of Medication Use
  • Causal Inference

Languages

  • English

Academic Information

  • Departments: Internal Medicine - Associate Professor
  • Divisions: Biostatistics, Epidemiology

Academic Office Information

  • 801-755-1955
  • Veterans Administration Medical Center
    SL IDEAS Center (182)
    500 S Foothill Blvd
    Salt Lake City, UT 84149

Academic Bio

My research interests include pharmacoepidemiology, comparative effectiveness research, medical informatics, and causal inference. My goals are to develop new knowledge and methods that improve the research process and realize them in applied research. We are accomplishing this by improving our theoretical understanding of research and causal inference. We are also developing methods to improve the transparency and reproducibility of our database research. I have received funding from the Veterans Health Administration and the Observational Medical Outcomes Partnership (OMOP) to develop Transparent ReUsable database and Statistical Tools (TRUST), which are analytic modules that execute specific data transformation and analytic tasks. Modules are compiled to develop workflows that can be automated, shared and reused by other investigators. We want to establish a social network of epidemiologists, biostatisticians and health services research for the purpose of collaborating and sharing research materials such as program code and analytic modules.

I serve on multiple working groups to develop guidelines for database management and observational comparative effectiveness research. I have used my role as one of the COIN center analytic core leads to develop and implement templates and standard operating procedures for epidemiological data management. We are also developing principles of epidemiologic data management and a framework for integrating project plans across research teams and roles.

Education History

Type School Degree
Graduate Training University of Utah
Public Health Informatics
M.S.
Fellowship Veterans Affairs Medical Center
Medical Informatics
Fellow
Doctoral Training University of Florida
Pharmacoepidemiology
Ph.D.
Undergraduate University of Florida
Psychology (Biological)
B.S.

Selected Publications

Journal Article

  1. Cannon GW, Erickson AR, Teng C-C, Huynh T, Austin S, Wade SW, Stolshek BS, Collier DH, Mutebiv A, Sauer BC ().

    Tumor Necrosis Factor Inhibitor Exposure and Radiographic Outcomes in Veterans with Rheumatoid Arthritis: A Longitudinal Cohort Study.

    . Rheumatology: Advances in Therapy.
  2. Monique E Cho, Jared L Hansen, Celena B Peters, Alfred K Cheung, Tom Greene, Brian C Sauer ().

    An Increased Mortality Risk is Associated With Abnormal Iron Status in Diabetic and Non-diabetic Veterans with Pre-dialysis Chronic Kidney Disease.

    . Kidney Int.
  3. Walsh JA, Pei S, Penmetsa G, Hansen JL, Cannon GW, Clegg DO, Sauer BC (2019 Mar 15). Identification of axial spondyloarthritis patients in a large dataset: the development and validation of novel methods.LID - jrheum.181005 [pii]LID - 10.3899/jrheum.181005 [doi]. (Epub ahead of print) J Rheumatol.
  4. Celena B Peters, Jared L Hansen, Ahmad Halwani, Monique E Cho, Jianwei Leng, Tina Huynh, Zachary Burningham, John Caloyeras, Tara Matsuda, Brian C Sauer ().

    Validation of Algorithms Used to Identify Red Blood Cell Transfusion Related Admissions in Veteran Patients With End Stage Renal Disease. 

    . GEMs.
  5. Bress AP, Dodson JA, King JB, Sauer BC, Reese T, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, LaFleur J (2018 Dec 1). Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. Am J Cardiol, 122(11), 1809-1816.
  6. Stever JR, Cannon GW, Teng CC, Accortt NA, Collier DH, Sauer BC (2018 Nov 12). Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry. (Epub ahead of print) Clin Exp Rheumatol.
  7. McCulley CB, Barton JL, Cannon GW, Sauer BC, Teng CC, George MD, Caplan L, England BR, Mikuls TR, Baker JF (2018 Nov 7). Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritis. (Epub ahead of print) Clin Exp Rheumatol.
  8. England BR, Sayles H, Michaud K, Thiele GM, Poole JA, Caplan L, Sauer BC, Cannon GW, Reimold A, Kerr GS, Baker JF, Mikuls TR (2018 Nov). Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival. Clin Rheumatol, 37(11), 2907-2915.
  9. George MD, Sauer BC, Teng CC, Cannon GW, England BR, Kerr GS, Mikuls TR, Baker JF (2018 Oct 1). Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis.LID - jrheum.180178 [pii]LID - 10.3899/jrheum.180178 [doi]. (Epub ahead of print) J Rheumatol.
  10. Erhardt DP, Cannon GW, Teng CC, Mikuls TR, Curtis JR, Sauer BC (2018 Sep 17). Low Persistence Rates in Rheumatoid Arthritis Patients Treated with Triple Therapy are Attributed to Adverse Drug Events Associated with Sulfasalazine.LID - 10.1002/acr.23759 [doi]. (Epub ahead of print) Arthritis Care Res (Hoboken).
  11. Bauer C, Sauer BG (2018 Sep 13). Growing and Retaining an Endoscopy Nurse.LID - S1542-3565(18)30976-5 [pii]LID - 10.1016/j.cgh.2018.09.014 [doi]. (Epub ahead of print) Clin Gastroenterol Hepatol.
  12. Walsh JA, Pei S, Penmetsa GK, Leng J, Cannon GW, Clegg DO, Sauer BC (2018 Sep 5). Cohort identification of axial spondyloarthritis in a large healthcare dataset: current and future methods. BMC Musculoskelet Disord, 19(1), 317.
  13. Jones BE, Haroldsen C, Madaras-Kelly K, Goetz MB, Ying J, Sauer B, Jones MM, Leecaster M, Greene T, Fridkin SK, Neuhauser MM, Samore MH (2018 Jul). In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia. Med Care, 56(7), 626-633.
  14. Baker JF, Sauer B, Teng CC, George M, Cannon GW, Ibrahim S, Cannella A, England BR, Michaud K, Caplan L, Davis LA, ODell J, Mikuls TR (2018 Jun). Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure. J Clin Rheumatol, 24(4), 203-209.
  15. Burningham Z, Leng J, Peters CB, Huynh T, Halwani A, Rupper R, Hicken B, Sauer BC (2018 May 17). Predicting Psychiatric Hospitalizations among Elderly Veterans with a History of Mental Health Disease. EGEMS (Wash DC), 6(1), 7.
  16. Baker JF, England BR, Mikuls TR, Sayles H, Cannon GW, Sauer BC, George MD, Caplan L, Michaud K (2018 Apr 29). Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis.LID - 10.1002/acr.23579 [doi]. (Epub ahead of print) Arthritis Care Res (Hoboken).
  17. Walsh JA, Pei S, Burningham Z, Penmetsa G, Cannon GW, Clegg DO, Sauer BC (2018 Mar). Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance. J Rheumatol, 45(3), 430-436.
  18. Nord JW Jr, Berry A, Stults B, Burningham Z, Beddhu S, Sauer BC (). Evaluation of the Effectiveness of a Patient-Centered Educational Mailer Designed to Improve Statin Adherence: A Pragmatic Trial. EGEMS (Wash DC), 4(1), 1256.
  19. Cheng Y, Nickman NA, Jamjian C, Stevens V, Zhang Y, Sauer B, LaFleur J (2018 Jan). Predicting poor adherence to antiretroviral therapy among treatment-naive veterans infected with human immunodeficiency virus. Medicine (Baltimore), 97(2), e9495.
  20. Cheng Y, Sauer B, Zhang Y, Nickman NA, Jamjian C, Stevens V, LaFleur J (2018 Jan). Adherence and virologic outcomes among treatment-naive veteran patients with human immunodeficiency virus type 1 infection. Medicine (Baltimore), 97(2), e9430.
  21. England BR, Baker JF, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Mikuls TR (2018 Jan). Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 70(1), 11-18.
  22. Jones BE, South BR, Shao Y, Lu CC, Leng J, Sauer BC, Gundlapalli AV, Samore MH, Zeng Q (2018 Jan). Development and Validation of a Natural Language Processing Tool to Identify Patients Treated for Pneumonia across VA Emergency Departments. Appl Clin Inform, 9(1), 122-128.
  23. George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, Ogdie-Beatty AR, Ibrahim S, Cannon GW, Caplan L, Sauer BC, Baker JF (2017 Dec). Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 69(12), 1789-1798.
  24. Burningham Z, He T, Teng CC, Zhou X, Nebeker J, Sauer BC (2017 Sep). Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection. Drug Saf, 40(9), 789-798.
  25. Walsh JA, Shao Y, Leng J, He T, Teng CC, Redd D, Treitler Zeng Q, Burningham Z, Clegg DO, Sauer BC (2017 Sep). Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans. Arthritis Care Res (Hoboken), 69(9), 1414-1420.
  26. Jones BE, Brown KA, Jones MM, Huttner BD, Greene T, Sauer BC, Madaras-Kelly K, Rubin MA, Bidwell Goetz M, Samore MH (). Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across. Infect Control Hosp Epidemiol, 38(8), 937-944.
  27. Jones BE, Brown KA, Jones MM, Huttner BD, Greene T, Sauer BC, Madaras-Kelly K, Rubin MA, Bidwell Goetz M, Samore MH (2017 Aug). Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers. Infect Control Hosp Epidemiol, 38(8), 937-944.
  28. Sauer BC, Teng CC, Accortt NA, Burningham Z, Collier D, Trivedi M, Cannon GW (2017 May 8). Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity. Arthritis Res Ther, 19(1), 86.
  29. Mohanty AF, Crook J, Porucznik CA, Johnson EM, Rolfs RT, Sauer BC (2017 Mar). Development and evaluation of a record linkage protocol for Utah's Controlled Substance Database. Health Informatics J, 23(1), 35-43.
  30. Sauer BC, Teng CC, Tang D, Leng J, Curtis JR, Mikuls TR, Harrison DJ, Cannon GW (2017 Mar). Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 69(3), 313-322.
  31. Lu CC, Leng J, Cannon GW, Zhou X, Egger M, South B, Burningham Z, Zeng Q, Sauer BC (2016 Dec). The use of natural language processing on narrative medication schedules to compute average weekly dose. Pharmacoepidemiol Drug Saf, 25(12), 1414-1424.
  32. Hernan MA, Sauer BC, Hernandez-Diaz S, Platt R, Shrier I (2016 Nov). Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J Clin Epidemiol, 79, 70-75.
  33. England BR, Sokolove J, Robinson WH, Thiele GM, Ganti AK, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer B, Singh N, Blair Solow E, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR (2016 Oct). Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis. Arthritis Rheumatol, 68(10), 2394-402.
  34. Baker JF, Sauer BC, Cannon GW, Teng CC, Michaud K, Ibrahim S, Jorgenson E, Davis L, Caplan L, Cannella A, Mikuls TR (2016 Aug). Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis. Arthritis Rheumatol, 68(8), 1818-27.
  35. Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Joseph GJ, Harrison DJ, Sauer BC (2016 Aug). Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis. Adv Ther, 33(8), 1347-59.
  36. Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW (2016). Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis. J Med Econ, 19(1), 34-43.
  37. Sauer BC, Jones BE, Globe G, Leng J, Lu CC, He T, Teng CC, Sullivan P, Zeng Q (2016). Performance of a Natural Language Processing (NLP) Tool to Extract Pulmonary Function Test (PFT) Reports from Structured and Semistructured Veteran Affairs (VA) Data. EGEMS (Wash DC), 4(1), 1217.
  38. England BR, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR (2016 Jan). Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 68(1), 36-45.
  39. Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, Goetz MB, Samore M (2015 Nov 1). Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010. Clin Infect Dis, 61(9), 1403-10.
  40. Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A (2015 Aug). A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf, 38(8), 749-65.
  41. Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A (2015 Aug). Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf, 38(8), 767-8.
  42. Jones BE, Sauer B, Jones MM, Campo J, Damal K, He T, Ying J, Greene T, Goetz MB, Neuhauser MM, Hicks LA, Samore MH (2015 Jul 21). Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study. Ann Intern Med, 163(2), 73-80.
  43. Smith EG, Austin KL, Kim HM, Eisen SV, Kilbourne AM, Miller DR, Zivin K, Hannemann C, Sauer BC, Valenstein M (2015 Jul). Mortality associated with lithium and valproate treatment of US Veterans Health Administration patients with mental disorders. Br J Psychiatry, 207(1), 55-63.
  44. Walsh JA, Zhou X, Clegg DO, Teng C, Cannon GW, Sauer B (2015 Apr). Mortality in American Veterans with the HLA-B27 gene. J Rheumatol, 42(4), 638-44.
  45. Nelson SD, Lu CC, Teng CC, Leng J, Cannon GW, He T, Zeng Q, Halwani A, Sauer B (2015 Jan). The use of natural language processing of infusion notes to identify outpatient infusions. Pharmacoepidemiol Drug Saf, 24(1), 86-92.
  46. Smith EG, Austin KL, Kim HM, Miller DR, Eisen SV, Christiansen CL, Kilbourne AM, Sauer BC, McCarthy JF, Valenstein M (2014 Dec 17). Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study. BMC Psychiatry, 14(1), 357.
  47. Sauer B, Nebeker J, Shen S, Rupper R, West S, Shinogle JA, Xu W, Lohr KN, Samore M (). Methodological framework to identify possible adverse drug reactions using population-based administrative data [http://f1000r.es/3ys] (doi: 10.12688/f1000research.4816.1). F1000Res, 3, 258.
  48. Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Harrison DJ, Joseph GJ, Sauer BC (2014 Oct). Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis. J Rheumatol, 41(10), 1935-43.
  49. Lonardo NW, Mone MC, Nirula R, Kimball EJ, Ludwig K, Zhou X, Sauer BC, Nechodom K, Teng C, Barton RG (2014 Jun 1). Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med, 189(11), 1383-94.
  50. Lucila Ohno-Machado, Zia Agha, Douglas S Bell, Lisa Dahm, Michele E Day, Jason N Doctor, Davera Gabriel, Maninder K Kahlon, Katherine K Kim, Michael Hogarth, Michael E Matheny, Daniella Meeker, Jonathan R Nebeker, Frederic Resnic, Dmitry Khodyakov, Lattice Armstead, Travis Nagler, Sam Morley, Nicholas Anderson, Dan Cooper, Dan Phillips, David Heber, Zhaoping Li, Michael K Ong, Ayan Patel, Marianne Zachariah, Jane C Burns, Lori B Daniels, Son Doan, Claudiu Farcas, Rita Germann-Kurtz, Xiaoqian Jiang, Hyeon-eui Kim, Paulina Paul, Howard Taras, Adriana Tremoulet, Shuang Wang, Wenhong Zhu, Douglas Berman, Angela Rizk-Jackson, Mike DArcy, Carl Kesselman, Tara Knight, Laura Pearlman, Paul Heidenreich, Dena Rifkin, Carl Stepnowsky, Tania Zamora, Scott L DuVall, Lewis J Frey, Jeffrey Scehnet, Brian C Sauer, Julio C Facelli, Ram K Gouripeddi, Jason Denton, Fern FitzHenry, James Fly, Vincent Messina, Freneka Minter, Lalit Nookala, Heidi Sullivan, Theodore Speroff, Dax Westerman (). pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J Am Med Inform Assoc, online, amiajnl-2014-00.
  51. Hope C, Estrada N, Weir C, Teng CC, Damal K, Sauer BC (2014 Apr 3). Documentation of delirium in the VA electronic health record. BMC Res Notes, 7(1), 208.
  52. Sauer B, Nebeker J, Shen S, Rupper R, West S, Shinogle JA, Xu W, Lohr KN, Samore M (2014). Methodological framework to identify possible adverse drug reactions using population-based administrative data. F1000Res, 3, 258.
  53. Sauer BC, Brookhart MA, Roy J, VanderWeele T (2013 Nov). A review of covariate selection for non-experimental comparative effectiveness research. Pharmacoepidemiol Drug Saf, 22(11), 1139-45.
  54. Walsh J, Sauer B, Clegg DO, Cannon GW, Zhou X, Teng C (). Mortality In United States Veterans With The HLA-B27 Gene. Arthritis Rheum, 65(10), 2778.
  55. Sills MR, Kwan BM, Yawn BP, Sauer BC, Fairclough DL, Federico MJ, Juarez-Colunga E, Schilling LM (). Medical home characteristics and asthma control: A prospective, observational cohort study protocol. EGEMS (Wash DC), 1(3), 12.
  56. Porucznik CA, Johnson EM, Rolfs RT, Sauer BC (2013 May-Jun). Opioid prescribing knowledge and practices: provider survey following promulgation of guidelines-Utah, 2011. J Opioid Manag, 9(3), 217-24.
  57. Porucznik CA, Crook J, Johnson EM, Rolfs RT, Sauer BC (). Specialty of Prescribers Associated with Opioid Fatalities in Utah, 2002-2010. Pain Med, 15(1), 5.
  58. Johnson EM, Lanier WA, Merrill RM, Crook J, Porucznik CA, Rolfs RT, Sauer B (2013 Apr). Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009. J Gen Intern Med, 28(4), 522-9.
  59. Gundlapalli A, Divita G, Carter M, Shen S, Palmer M, Forbush T, South B, Redd A, Sauer B, Samore M (). Extracting Surveillance Data from Templated Sections of an Electronic Medical Note: Challenges and Opportunities. OJPHI, 5(1).
  60. Cheng M, Sauer B, Johnson E, Porucznik C, Hegmann K (2013 Mar). Comparison of opioid-related deaths by work-related injury. Am J Ind Med, 56(3), 308-16.
  61. Sauer, BC, Helper CD (). Application of system-level root cause analysis for drug quality and safety problems: A case study. Res Social Adm Pharm, 9(1), 49-59.
  62. Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Sturmer T, West SL, Schneeweiss S (). The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf, 22(1), 1-6.
  63. Sills MR, Kwan BM, Yawn BP, Sauer BC, Fairclough DL, Federico MJ, Juarez-Colunga E, Schilling LM (2013). Medical home characteristics and asthma control: a prospective, observational cohort study protocol. EGEMS (Wash DC), 1(3), 1032.
  64. Nelson RE, Nebeker JR, Sauer BC, LaFleur J (2012 Apr). Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone, 50(4), 983-8.
  65. Hope CJ, Garvin JH, Sauer BC (2012 Mar 15). Information extraction from narrative data. Am J Health Syst Pharm, 69(6), 455, 460-1.
  66. Hall GC, Sauer B, Bourke A, Brown JS, Reynolds MW, LoCasale R (2012 Jan). Guidelines for good database selection and use in pharmacoepidemiology research. Pharmacoepidemiol Drug Saf, 21(1), 1-10.
  67. Cannon GW, Mikuls TR, Hayden CL, Ying J, Curtis JR, Reimold AM, Caplan L, Kerr GS, Richards JS, Johnson DS, Sauer BC (2011 Dec). Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. Arthritis Care Res (Hoboken), 63(12), 1680-90.
  68. LaFleur J, Nelson RE, Sauer BC, Nebeker JR (2011 Nov). Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart, 97(22), 1862-9.
  69. Porucznik CA, Johnson EM, Sauer B, Crook J, Rolfs RT (). Studying Adverse Events Related to Prescription Opioids: The Utah Experience. Pain Med, 12(s2), S16-S25.
  70. Porucznik CA, Sauer BC, Johnson EM, Crook J, Wrathall J, Anderson JW, Rolfs RT (). Adult Use of Prescription Opioid Pain Medications-Utah 2008. JAMA, 303(14), 1359-1361.
  71. Johnson E, Bateman KA, Rolfs R, Sauer BC (). The Leading Cause of Accidental Death in One US State – the Use of Prescription Drugs. Hosp Manage.
  72. Rubin MA, Mayer J, Greene T, Sauer BC, Hota B, Trick W, Jernigan JA, Samore MH (2008 Nov 6). An agent-based model for evaluating surveillance methods for catheter-related bloodstream infection. AMIA Annu Symp Proc, 631-5.
  73. Nebeker JR, Yarnold PR, Soltysik RC, Sauer BC, Sims SA, Samore MH, Rupper RW, Swanson KM, Savitz LA, Shinogle J, Xu W (2007 Oct). Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data. Med Care, 45(10 Supl 2), S81-8.
  74. Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M (2007 Oct). Out-of-pocket pharmacy expenditures for veterans under medicare part D. Med Care, 45(10 Supl 2), S77-80.
  75. Samore, MH, Shen, S, Greene, T, Stoddard, G, Sauer, B, Shinogle, J, Nebeker, J, Harbarth, S (Oct. 2007). A Simulation-based Evaluation of Methods to Estimate the Impact of an Adverse Event on Hospital Length of Stay. Med Care, 45(10 (Supl 2)), S108-15.
  76. Sauer BC, Hepler CD, Cherney B, Williamson J (2007 Jan). Computerized indicators of potential drug-related emergency department and hospital admissions. Am J Manag Care, 13(1), 29-35.
  77. Ried LD, Tueth MJ, Taylor MD, Sauer BC, Lopez LM, Pepine CJ (2006 Apr). Depressive symptoms in coronary artery disease patients after hypertension treatment. Ann Pharmacother, 40(4), 597-604.
  78. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC (2005 Apr 1). Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm, 62(7), 714-9.
  79. Winterstein AG, Sauer BC, Hepler CD, Poole C (2002 Jul-Aug). Preventable drug-related hospital admissions. Ann Pharmacother, 36(7-8), 1238-48.
  80. Burningham Z, Chen W, Sauer BC, Richter Lagha R, Hansen J, Huynh T, Patel S, Leng J, Halwani A, Kramer B Josea ().

    VHA Geriatric Scholars Program’s Impact on Prescribing Potentially Inappropriate Medications.

    . Am J Manag Care.

Review

  1. Bourke A, Bate A, Sauer BC, Brown JS, Hall GC (2016 Jul). Evidence generation from healthcare databases: recommendations for managing change. [Review]. Pharmacoepidemiol Drug Saf, 25(7), 749-54.

Book Chapter

  1. Li L, Greene T, Sauer BC (). Chapter 7: Propensity score analysis with matching weights. In Pan W, Bai H (Eds.), Propensity Score Analysis: Fundamentals and Developments (2). New York: Guilford Press.
  2. Sauer B, Vanderweele T (). Supplement 2: The Use of Directed Acyclic Graphs on Non-experimental Comparative Effectiveness Research. In Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM (Eds.), Developing a Protocol for Observational Comparative Effectiveness Research: A Users Guide. Rockville: Agency for Healthcare Research and Quality.
  3. Sauer B, Brookhart MA, Roy JA, VanderWeele TJ (). Chapter 7: Covariate Selection. In Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM (Eds.), Developing a Protocol for Observational Comparative Effectiveness Research: A Users Guide. Rockville: Agency for HealthCare Research and Quality.

Conference Proceedings

  1. Halwani, A, Patil, V, Rasmussen, KM, Li, C, Burningham, Z, Friedman, DR, Kelley, MJ, Sauer, BC (). Predicting Prostate Cancer Diagnosis and Diagnosis Date using ICD Codes with XGBoost Supervised Representation. Newport, RI.
  2. Halwani, A, Burningham, Z, Rasmussen, KM, Patil, V, Narayanan, S, Lin, S, Carroll, S, Hsu, L, Graff, JN, Dreicer, R, Gupta, S, Low, CA, Sauer, BC (). Practice Patterns in Metastatic Castration-Resistant Prostate Cancer (mCRPC): Evidence from the Veterans Health Administration. Madrid, Spain: European Society for Medical Oncology.
  3. Rasmussen, KM, Patil, V, Li, C, Sauer, BC, Halwani, A (). Understand the Survival Outcomes of Black and White Veterans with Metastatic Castration-Resistant Prostate Cancer (mCRPC). 2018 AVAHO Meeting, Chicago, IL: Association of VA Hematology/Oncology.
  4. Halwani, A, Rasmussen, KM, Patil, V, Burningham, Z, Li, C, Yong, C, Masaquel, A, Henderson, K, Delong-Sieg, E, Sauer, BC (). Factors Associated with Overall Survival in Follicular Lymphoma Patients Who Are Eligible for Maintenance Therapy. ASH Annual Meeting, San Diego, CA: America Society of Hematology..
  5. Halwani, A, Rasmussen, KM, Patil, V, Li, C, Yong, C, Burningham, Z, Schulz, M, Li J, Masaquel, A, Halloran, M, Delong-Sieg, E, Sauer, BC (). Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration. ASH Annual Meeting, San Diego, CA: America Society of Hematology.
  6. Halwani, A, Friedman, DR, Patil, V, Rasmussen, KM, Sauer, BC, Kelley, MJ (). VA Symptom Assessment Scale (VSAS): Symptom Prevalence, Reliability and Internal Consistency. 2018 AVAHO Meeting, Chicago, IL: Association of VA Hematology/Oncology.
  7. Patil, V, Rasmussen, KM, Burningham, Z, Low, C, Gupta, S, Sauer, BC, Halwani, A (). Using Natural Language Processing in Radiology Reports to Identify the Presence of Metastatic Disease in Veterans with Prostate Cancer. 2017 AVAHO Meeting, Denver, CO: Association of VA Hematology/Oncology.
  8. Patil, V, Rasmussen, KM, Sauer, BC, Halwani, A (). Implementation of Chemo and Anti-Neoplastic Extractor Cycle and Regimen Estimator (CANCER CARE) in Follicular Lymphoma Patients Treated in VA. 2018 AVAHO Meeting, Chicago, IL: Association of VA Hematology/Oncology.
  9. Halwani, A, Rasmussen, KM, Patil, V, Burningham, Z, Low, C, Meissner, B, Kapustyan, T, Keim, H, Lawrence, N, Walker, J, Sauer, BC (). Examining methods for systematically identifying cytogenetic testing among Chronic Lymphoblastic Leukemia patients. 2017 AVAHO Annual Meeting, Denver, CO: Association of VA Hematology/Oncology.
  10. Rasmussen, KM, Patil, V, Burningham, Z, Narayanan, S, Lin, S, Carroll, S, Hsu, L, Graff, JN, Dreicer, R, Gupta, S, Low, CA, Sauer, BC, Halwani, A (). The Role of Academic Affiliation in the Treatment of Metastatic Castrate-Resistant Prostate Cancer in the Veterans Health Administration. 2017 AVAHO Meeting, Denver, CO: Association of VA Hematology/Oncology.
  11. Halwani AS, Patil V, Rasmussen KM, Friedman DR, Li C, Burningham Z, Humpherys J, Sauer BC, Kelly MJ ().

    Leveraging Machine Learning to Predict Prostate Cancer Diagnosis and Diagnosis Date Using International Classification of Diseases (ICD) Codes with Gradient Boosted Decision Trees

    . Newport, RI.: American Association for Cancer Research (AACR) Conference.
  12. Sauer B, Teng CC, Leng J, Mikuls TR, Curtis JR, Stolshek BS, Tang D, Cannon GW (). Higher Persistence and Adherence with Combination Therapy with Tumor Necrosis Factor Inhibitor+Methotrexate Combination Versus Triple Therapy in US Veterans with Rheumatoid Arthritis. 2015 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 67(suppl 10).
  13. Cannon GW, DuVall SL, Hayden CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold AM, Collier DH, Joseph G, Harrison DJ, Sauer BC (). US Veterans With Rheumatoid Arthritis Who Switch Among Tumor Necrosis Factor Blocking Agents Have No Additional Clinical Benefit With The Change In Therapy and Incur Higher Costs. 2013 ACR/ARHP Annual Meeting.
  14. Sauer BC, Teng MS CC, Accortt NA, Collier DH, Lin TC, Cannon GW (). Thresholds for Disease Activity Measures DAS28, CDAI, and RAPID3 Do Not Align with Clinical Practice Patterns of Rheumatoid Arthritis (RA) Disease Management Decisions. 2018 ACR/ARHP Annual Meeting, 70(suppl 10).
  15. Cannon GW, Teng C-C, He T, Leng J, Lu C-C, Tang D, Shah N, Harrison DJ, Sauer B (). Estimation of Cost per Effectively Treated Patients with Biologic Disease Modifying Anti-Rheumatic Drugs in US Veterans with Rheumatoid Arthritis. 2014 ACR/ARHP Annual Meeting, Arthritis Rheumatol.
  16. Sauer B, Teng C-C, He T, Leng J, Lu C-C, Shah N, Harrison DJ, Tang D, Cannon GW (). Treatment Patterns of Biologics Used in Rheumatoid Arthritis and Ankylosing Spondylitis in the US Veterans Population. 2014 ACR/ARHP Annual Meeting, Arthritis Rheumatol.
  17. Cannon GW, Rogas J, Bell N, Baker J, Kerr GS, Gaffo A, Richards JS, Barton J, Schwab P, Mikuls TR, Singh N, Caplan L, Lazaro D, Reimold A, Sauer B (). An Electronic Audit, Reporting, and Data Correction System Improves the Quantity and Quality of Observational Data Collected for US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  18. Rasmussen KM, Patil V, Li C, Sauer BC, Halwani A ().

    Survival Rates of Black and White Veterans With Metastatic Castration-Resistant Prostate Cancer

    . Annual Meeting, Chicago, IL: Association of VA Hematology/Oncology (AVAHO).
  19. Lammert KR, Erickson AR, Sauer BC, Cannon GW (). Clinical Radiology Reports Are Unreliable for Assessment of Radiographic Structural Progression in US Veterans with Rheumatoid Arthritis Initiating Tumor Necrosis Factor Inhibitor Therapy. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  20. Patel S, Anderson ZL, Cannon GW, Sauer BC, Miller KL (). A Customized Health Information Technology Effectively Identifies and Directs Bone Health Services in Rural Veterans with Osteoporosis Risk Factors. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  21. Overbury RS, Pei S, Penmetsa G, Cannon GW, Clegg DO, Sauer B, Walsh J (). Identification of Axial Spondyloarthritis Patients in a Large Dataset: The Development and Validation of Novel Methods. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  22. OConnor A, Baker J, England BR, Sauer BC, Cannon GW, Richards JS (). Variation in Predictors of Patient and Physician Defined Flares in Rheumatoid Arthritis. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  23. England BR, Sayles H, Roul P, Ganti A, Sokolove J, Robinson WH, Cannon GW, Sauer B, Baker J, Thiele GM, Mikuls TR (). Serum Cytokine and Chemokine Concentrations Predict Incident Cancer in US Veterans with Rheumatoid Arthritis. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  24. Hlser ML, Sauer BC, Milch HM, Schreiyck C, Luo Y, Bozec A, Schett G, Mller-Ladner U, Neumann E (). Comparison of Metabolic Changes in Osteoarthritis and Rheumatoid Arthritis Mouse Models. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  25. Stever JR, Sauer BC, Cannon GW (). Comprehensive Provider Judgement Is a Significant Determinant of Major Therapeutic Change in Patients with Moderate to Severe Rheumatoid Arthritis. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  26. England BR, Roul P, Sauer B, Pei S, Cannon GW, Baker J, Mikuls TR (). Derivation of a National Rheumatoid Arthritis Cohort in the Veterans Health Administration and Validation with the Veterans Affairs Rheumatoid Arthritis Registry. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  27. Brittan K, Roul P, Baker J, Sauer B, Singh N, Sayles H, Cannon GW, Mikuls TR, England BR (). Risk of Prostate Cancer in US Veterans with Rheumatoid Arthritis. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  28. Singh N, Gao Y, England BR, Roul P, Field E, Baker J, Sauer B, Mikuls TR, Cannon GW, Curtis JR, Vaughan-Sarrazin M, Lynch C (). All Site Cancers and Lymphoma Incidence in US Veterans with Rheumatoid Arthritis 2001-2015. 2018 ACR/ARHP Annual Meeting, Arthritis Rheumatol, 70(suppl 10).
  29. Cannon, GW, Erickson, AR, Teng, C-C, Huynh, T, Austin, S, Stolshek, BS, Mutebi, A, Collier, D, Wade, SW, Sauer, B (). Impact of Adherence to Tumor Necrosis Factor Inhibitors on Radiographic Outcomes in US Veterans with Rheumatoid Arthritis. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  30. Cannon, G, Teng, C-C, Accortt, NA, Collier, DH, Lin, T-C, Sauer, BC (). FRI0018 The Ability of Disease Activity Measures to Predict Major Therapeutic Change in US Veterans with Rheumatoid Arthritis. BMJ Publishing Group Ltd.
  31. Cannon, GW, Teng, CC, Tang, DH, Leng, J, Harrison, DJ, Sauer, B (). FRI0113 Persistence and Adherence with Triple Therapy and Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy in US Veterans with Rheumatoid Arthritis. BMJ Publishing Group Ltd.
  32. Walsh, JA, Pei, S, Burningham, Z, Penmetsa, G, Cannon, GW, Clegg, DO, Sauer, BC (). Use of Disease-Modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance. The Journal of Rheumatology, (jrheum. 17).
  33. Baker, J, Sauer, B, Teng, C-C, Cannon, GW, Ibrahim, S, George, M, Cannella, AC, England, BR, Caplan, L, Davis, LA (). Changes in Blood Pressure Following the Initiation of Disease Modifying Therapies in US Veterans with Rheumatoid Arthritis. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  34. George, MD, Giles, JT, Katz, PP, Ibrahim, S, Cannon, GW, England, BR, Caplan, L, Sauer, B, Michaud, K, Mikuls, TR (). C-Reactive Protein and Disease Activity in Rheumatoid Arthritis: Impact of Obesity and Adiposity. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  35. Brown, J, Bate, A, Platt, R, Raebel, M, Sauer, B, Trifiro, G (). Real-World Battles with Real-World Data. Pharmacoepidemiology and Drug Safety, 26, 254-255.
  36. Sauer, B, Stever, JR, Teng, C-C, Accortt, N, Collier, D, Cannon, G (). Influences for Therapeutic Changes in Rheumatoid Arthritis Patients from the Veterans Affairs Rheumatology Arthritis Registry Who Have Moderate to High Disease Activity. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  37. Cannon, GW, Mehortra, S, South, B, Mikuls, TR, Reimold, AM, Sauer, BC (). A Natural Language Processing System Can Capture Rheumatoid Arthritis Disease Activity Measures in US Veterans Across Multiple Sites. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  38. Walsh, JA, Burningham, Z, Teng, C-C, Clegg, DO, Sauer, BC (). Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  39. England, BR, Baker, JF, Sayles, H, Michaud, K, Caplan, L, Davis, LA, Cannon, GW, Sauer, B, Solow, EB, Reimold, A (). Baseline Obesity and Subsequent Weight Loss Are Independently Associated with Cardiovascular Mortality in Established Rheumatoid Arthritis. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10).
  40. George, MD, Sauer, B, Teng, C-C, Cannon, G, England, BR, Kerr, GS, Mikuls, TR, Baker, J (). Predictors of Earlier Biologic Initiation Among Patients with Rheumatoid Arthritis Starting Methotrexate. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  41. Halwani, AS, Rasmussen, K, Patil, V, Burningham, Z, Sauer, BC (). Incidence of Atrial Fibrillation and Bleeding in CLL Patients Treated with Ibrutinib: Evidence from the Veterans Health Administration. Atlanta, GA: American Society of Hematology, 130(suppl 1), 5336.
  42. Erhardt, D, Sauer, B, Teng, C, Mikuls, TR, Curtis, JR, Tang, D, Stolshek, BS, Cannon, GW (). Clinical Practice Experience in Rheumatoid Arthritis Patients Treated with Triple Therapy and Methotrexate-Tumor Necrosis Factor Inhibition Differs from That of Randomized Controlled Trials: Abstract Number: 3197. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10), 3836-3837.
  43. Erhardt, D, Sauer, BC, Teng, C-C, Mikuls, TR, Curtis, JR, Cannon, GW (). The Reasons for Discontinuation of Combination Therapy with Methotrexate and Tumor Necrosis Factor Inhibitors Versus Triple Therapy Differ Significantly Because of Higher Adverse Events with Triple Therapy. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  44. Halwani, A, Rasmussen, KM, Patil, V, Burningham, Z, Narayanan, S, Lin, S-W, Carroll, S, Hsu, L-I, Graff, JN, Dreicer, R, Sauer, B (). Abstract A055: Racial Disparities in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): Evidence from the Veterans Health Administration (VHA). AACR Special Conference: Prostate Cancer: Advances in Basic, Translational, and Clinical Research, Orlando, FL: American Association for Cancer Research, 78(16), A055.
  45. Cannon, G, Rojas, J, Bell, N, Reimold, A, Mikuls, TR, Singh, N, Kerr, GS, Schwab, P, Barton, J, Caplan, L (). The Use of Natural Language Processing to Identify, Retrieve, Report, and Correct Observational Data on US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  46. Mcculley, CB, Barton, J, Cannon, G, Sauer, B, Teng, C, Caplan, L, England, B, Mikuls, T, Baker, J (). 37 Bmi and Persistence of Conventional DMARDS & TNF Inhibitors in Rheumatoid Arthritis. Journal of Investigative Medicine, 66(1), A77-A78.
  47. Baker, JF, England, BR, Mikuls, TR, Sayles, H, Cannon, GW, Sauer, BC, George, MD, Caplan, L, Michaud, K (). Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis. Arthritis Care & Research.
  48. Jones, BE, Sauer, B, South, B, Leng, J, Xi, Z, Lu, C, He, T, Nechodom, K, Jones, M, Greene, T (). The Need for NLP: Limitations of Diagnostic Coding for Population Studies of Pneumonia. American Thoracic Society, A1779-A1779.
  49. Cheng, Y, Egger, M, Chen, W, Lafleur, J, Sauer, B (). A Simulation Study to Explore Bias Generated When Conditioning on an Intermediate Variable That Is Also a Time-varying Confounder: 990. Pharmacoepidemiology and Drug Safety, 24, 564-565.
  50. Bress, A, Dodson, J, Sauer, B, DuVall, S, Crook, J, Reese, T, Hartsfield, C, Koch, B, Nelson, R, LaFleur, J (). Ranolazine Use Following Initial Anti-anginal Therapy Is Associated With Lower Health Resource Utilization Among US Veterans With Chronic Stable Angina. American Heart Association, Inc..
  51. McCulley, C, Barton, J, Cannon, G, Sauer, B, Teng, C, George, M, Caplan, L, Caplan, B, Mikuls, T, Baker, J (). Body Mass Index and Persistence of Conventional Dmards and TNF Inhibitors in Rheumatoid Arthritis. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  52. Sauer, B, Teng, C-C, Accortt, N, Burningham, Z, Collier, D, Trivedi, M, Cannon, GW (). Models Using Claims-Based Administrative Data Are Poor Predictors of Rheumatoid Arthritis Disease Activity in VA Rheumatoid Arthritis (VARA) Patients. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  53. England, BR, Sayles, H, Michaud, K, Caplan, L, Davis, LA, Cannon, GW, Sauer, B, Solow, EB, Reimold, A, Kerr, GS (). Associations of Chronic Lung Comorbidity with Medications, Disease Activity, and All-Cause Mortality in Rheumatoid Arthritis. 2016 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 68(suppl 10).
  54. Jones, BE, Sauer, B, South, B, Leng, J, Xi, Z, Lu, CC, He, T, Nechodom, K, Jones, M, Greene, T (). A47 CLINICAL ASPECTS AND DIAGNOSIS OF RESPIRATORY TRACT INFECTIONS: The Need For Nlp: Limitations Of Diagnostic Coding For Population Studies Of Pneumonia. American Journal of Respiratory and Critical Care Medicine, 191, 1.
  55. Halwani, AS, Rasmussen, K, Patil, V, Burningham, Z, Low, C, Reyes, CM, Masaquel, A, Henderson, K, Delong-Sieg, E, Sauer, BC (). Maintenance Rituximab after First Line Treatment in Veterans with Follicular Lymphoma Is Associated with Prolonged Overall Survival. Atlanta, GA: American Society of Hematology, 130(Suppl 1), 1489.
  56. Stever, JR, Sauer, B, Teng, C-C, Accortt, N, Collier, D, Cannon, G (). Comprehensive Provider Judgment Outweighs Disease Activity Measures in the Decision to Not Escalate Therapy in Patients with Moderate to Severe Rheumatoid Arthritis. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  57. Cannon, G, Erickson, AR, Teng, C-C, Huynh, T, Wade, SW, Stolshek, BS, Collier, D, Mutebi, A, Sauer, BC (). Increased Cumulative Exposure to Tumor Necrosis Factor Inhibitors Reduces Radiographic Progression in US Veterans with Rheumatoid Arthritis in Real World Clinical Practice. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  58. Baker, J, Mikuls, TR, England, BR, George, MD, Cannon, G, Sayles, H, Sauer, B, Caplan, L, Michaud, K (). Impact of Body Mass Index and Weight Loss on Incident Disability in Patients with Rheumatoid Arthritis. 2017 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 69(suppl 10).
  59. Cannon, GW, Mehrotra, S, Sauer, BC (). AB1089 Use of Natural Language Processing to Enhance Retrieval of Rheumatoid Arthritis Disease Activity Outcomes Measures in US Veterans. BMJ Publishing Group Ltd.
  60. Cannon, GW, Teng, CC, Accortt, NA, Collier, D, Mehrotra, S, Sauer, BC (). THU0102 Clinical Disease Activity Measures are Important Drivers of Major Change in Medical Treatment in US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) Registry. BMJ Publishing Group Ltd.
  61. Cannon, GW, Teng, C-C, Accortt, N, Collier, D, Trivedi, M, Sauer, BC (). AB0193 The Utility of Using Administrative Data To Stratify US Veterans with Rheumatoid Arthritis on The Basis of Disease Activity. BMJ Publishing Group Ltd.
  62. Sauer, BC, Teng, C-C, Accortt, NA, Burningham, Z, Collier, D, Trivedi, M, Cannon, GW (). Models Solely Using Claims-Based Administrative Data are Poor Predictors of Rheumatoid Arthritis Disease Activity. Arthritis Research & Therapy, 19(1), 86.
  63. Munger, MA, Nelson, SD, Teng, C-C, Bress, A, Sauer, BC (). Reduced Risk of NSAID Induced Adverse Events With Concomitant SE of Misoprostol. Journal of the American College of Cardiology, 69(11 Suppl), 1759.
  64. Cannon, GW, Teng, CC, Accortt, N, Collier, D, Trivedi, M, Sauer, BC (). AB1005 Multiple Modeling Methods of Administrative Data Yield Consistent Results but Limited Ability To Predict Rheumatoid Arthritis Disease Activity in US Veterans. BMJ Publishing Group Ltd, 75, 1245.
  65. Halwani, A, Burningham, Z, Rasmussen, K, Patil, V, Low, C, Reyes, C, Masaquel, A, Henderson, K, DeLong-Sieg, E, Nixon, M, Sauer, BC (). Have First Line Practice Patterns in the Treatment of Follicular Lymphoma Changed with the Adoption of Maintenance Rituximab? Clinical Lymphoma, Myeloma and Leukemia, 17, S363-S364.
  66. Cannon, GW, Mehortra, S, South, BR, Leng, J, Lu, CC, Sauer, BC (). THU0612 Development and Validation of An Accurate and Precise Natural Language Processing System To Capture Rheumatoid Arthritis Disease Activity Measures. BMJ Publishing Group Ltd, 75, 414.
  67. Halwani, AS, Burningham, Z, Rasmussen, KM, Patil, V, Low, CA, Meissner, B, Kapustyan, T, Lawrence, N, Walker, J, Keim, H (). Cytogenetic and Fluorescence In Situ Hybridization Testing in Veterans with Chronic Lymphocytic leukemia. American Society of Clinical Oncology.
  68. Halwani, A, Burningham, Z, Sauer, B (). Epidemiology of Common Lymphoid Malignancies in the Veteran Health Administration. Clinical Lymphoma, Myeloma and Leukemia, 16, S113.
  69. Halwani, A, Burningham, Z, Rasmussen, KM, Patil, V, Narayanan, S, Lin, S-W, Carroll, S, Hsu, L, Graff, JN, Dreicer, R, Gupta, S, Low, CA, Sauer, BC (). 804PPractice Patterns in Metastatic Castration-Resistant Prostate Cancer (mCRPC): Evidence From the Veterans Health Administration. Annals of Oncology, 28(suppl_5).
  70. George, MD, Giles, JT, Katz, PP, England, BR, Mikuls, TR, Michaud, K, OgdieBeatty, AR, Ibrahim, S, Cannon, GW, Caplan, L, Sauer BC (). Impact of Obesity and Adiposity on Inflammatory Markers in Patients with Rheumatoid Arthritis. Arthritis Care & Research, 69(12), 1789-1798.
  71. Sauer, BC, Teng, C-C, Accord, N, Trivedi, MM, Collier, DH, Cannon, GW (). Claims-Based Prediction Models Are Unable to Accurately Predict Disease Activity for Rheumatoid Arthritis. Pharmacoepidemiology and Drug Safety, 25, 1759.
  72. England, BR, Sokolove, J, Robinson, WH, Thiele, GM, Ganti, AK, Sayles, H, Michaud, K, Caplan, L, Davis, LA, Cannon, GW (). Circulating Cytokine/chemokine Concentrations Predict Cancer Mortality in Men with Rheumatoid Arthritis: abstract Number: 3236. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10), 3879-3881.
  73. Jones, BE, Brown, KA, Jones, MM, Huttner, B, Greene, T, Sauer, B, Madaras-Kelly, K, Rubin, M, Goetz, MB, Samore, M (). Variation In Detection And Coverage Of Resistant Pathogens In Hospitalized Veterans With Pneumonia At 128 Medical Centers. American Thoracic Society, A2104-A2104.
  74. Baker, J, Sauer, B, Michaud, K, Cannon, GW, Ibrahim, S, Caplan, L, Davis, LA, Cannella, AC, Mikuls, TR (). initiation of Disease Modifying Therapies and Subsequent Weight Change in Rheumatoid Arthritis: abstract Number: 1564. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10), 1955-1956.
  75. Akoum, N, Bader, F, Ghanem, M, Stenehjem, D, Burningham, Z, Sauer, BC (). Comparison of the Effectiveness and Side Effects of Dofetilide and Dronedarone in the Treatment of Atrial Fibrillation During an Indicated Period in Time with Perceived Equipoise. F1000Research, 5.
  76. Sauer, B, Teng, C, He, T, Leng, J, Lu, C, Walsh, J, Shah, N, Harrison, DJ, Tang, D, Cannon, GW (). One-year Cost of Etanercept, Adalimumab, and Infliximab per Treated Patient with Chronic Inflammatory Arthritides in Us Veterans: abstract Number: 139. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10), 199-200.
  77. England, BR, Thiele, GM, Duryee, MJ, Klassen, L, Sokolove, J, Robinson, WH, Anderson, D, Sayles, H, Michaud, K, Caplan, L (). Associations of Serum Anti-malondialdehyde-acetaldehyde (maa) Antibodies with Cardiovascular and Respiratory Mortality in Men with Rheumatoid Arthritis: abstract Number: 1574. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10), 1964-1965.
  78. Cannon, GW, Teng, C, Mikuls, TR, Curtis, JR, Tang, D, Stolshek, BS, Sauer, B (). Initiation of Combination Triple Therapy in Real World Clinical Practice Rarely Replicates the Protocols Used in Randomized Controlled Trials. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10).
  79. Walsh, J, Leng, J, Breviu, B, Clegg, D, He, T, Sauer, B (). Identification Methods for Axial Spondyloarthritis in American Veterans: abstract Number: 697. 2015 ACR/ARHP Annual Meeting, Arthritis & Rheumatology, 67(suppl 10), 947-950.
  80. Sauer BC, Nebeker JR, Shen S, Rupper R, Samore M (). Identification of possible adverse drug reactions using population-based administrative data. In Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Thailand (Eds.), Patient Safety Annu Symp, Ubon, Thailand: ISBN 978-974-523-265-5 (Thailand), Proc. 2011, 60-66.
  81. Sauer, BC, He Tao, Nebeker JR (). SAS® Tools for Transparent and Reproducible Research: Medication History Estimator. SAS® Global Forum 2013 proceedings, San Francisco: SAS®, 1-10.
  82. Gundlapalli A, Divita G, Carter M, Shen S, Palmer M, Forbush T, South B, Redd A, Sauer B, Samore M (). Online Journal of Public Health Informatics. OJPHI, 5(1).
  83. DuVall SL, Kamauu AWC, Sauer BC (). Using Advanced Healthcare Data Analytics to Identify and Characterize Central Venous Catheterization Episodes Via Electronic Health Records in the Veterans Affairs. In Strom BL, Hasford J, Hennessy S, Park BJ (Eds.), 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Managment, Barcelona, Spain: Wiley-Blackwell, 21(supp 3), 308-309.
  84. Sauer B, Gardersdottir H, Liang H, Schuemie M, Klungel O, Ryan P (). Transparent, Reproducible and Reusable Research in Pharmacoepidemiology. 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Barcelona: ISPE.
  85. Gardardottir H, Sauer BC, Liang H, Ryan P, Klungel O, Reynolds R (). Transparent, Reproducible and Reusable Research in Pharmacoepidemiology. Pharmacoepidemiol Drug Saf, Hoboken: Wiley Periodicals, Inc., John Wiley & Sons, 21, 197-197.
  86. Duncan J, Grey T, Lenert L, Sauer B, Staes C (). Factors Affecting Quality of Cause of Death on Death Certificates. AMIA 2012 Annual Symposium, Chicago: JAMIA.
  87. Cannon GW, Sauer BC, Hayden CL, Pickard SG, Kerr GS, Richards JS, Johnson DS, Caplan L, Mikuls TR, Reimold AM (). Response with Combination Therapy - Methotrexate, Sulfasalazine, and Hydroxychloroquine - Appears Similar to the Response to Methotrexate and Anti-Tumor Necrosis Factor in US Veterans in the Veterans Affairs Rheumatoid Arthritis Registry. Arthritis and Rheumatism, Chicago: Wiley-Blackwell, 63(10), S482-S482.
  88. Sauer BC, Nebeker JR, Shen S, Rupper R, Samore M (). Identification of possible adverse drug reactions using population-based administrative data. In Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Thailand (Eds.), Patient Safety Annu Symp, Ubon, Thailand: ISBN 978-974-523-265-5 (Thailand), Proc. 2011, 60-66.
  89. Hayden CL, Sauer BC, Cannon GW (). Impact of including physician's prescribing directions on calculations of medication possession ratios - International Society for Disease Surveillance Conference 2010: Enhancing the Synergy Between Research, Informatics, and Practice in Public Health. Conference 2010: Enhancing the Synergy Between Research, Informatics, and Practice in Public Health, International Society for Disease Surveillance.
  90. Porucznik CA, Sauer BC, Sims SA, Rolfs RT (2008). Non-Illicit Drug Poisoning Deaths in Utah 1999-2004: How are legitimate prescriptions involved? In Porucznik CA, Sauer BC, Sims SA, Rolfs RT (Eds.), 41st Annual Society for Epidemiologic Research Meeting, Chicago, IL: American Journal of Epidemiology, 167(11), S120-S120.
  91. Rupper RW, Sauer BC, Shen S, South B, Bair BD (). Changes in utilization patterns for tele-health managed elderly patients - Conference in Seattle. Journal of the American Geriatrics Society, Blackwell Publishing, 55(4), S4-S4.
  92. Sauer B, Nebeker J, Rupper R, Samore M (). Serum Potassium Monitoring and Hyperkalemia in Veterans using Renin-Angiotensin-Aldosterone Inhibitors. HSR&D National Meeting, Arlington, VA.
  93. Ho MJ, Sauer B, Stockdale B, Brixner D (). PDB39 Development of an integrated diabetes database across community clinics and hospitals. Value Health, 8(3), 364.
  94. Sauer BC, Winterstein AG, Mattenklotz AM (). PM142 Design and validity of automated health care data screens to detect in-hospital adverse drug events. Value Health, 5(3), 225-226.
  95. Halwani, A, Rasmussen, KM, Patil, V, Li, C, Yong, C, Burningham, Z, Narayanan, S, Lin, S, Carroll, S, Mhatre, S, Graff, JN, Dreicer, R, Sauer, BC (). Real-World Practice Patterns in Veterans with Metastatic Castration-Resistant Prostate Cancer. The Journal of Urologic Oncology.

Letter

  1. Sauer B, Teng CC, Burningham Z, Cannon G (2015 Nov). Errata to NLP study of infusion notes to identify outpatient infusions in the VA [Letter to the editor]. Pharmacoepidemiol Drug Saf, 24(11), 1225-6.

Abstract

  1. Cannon, G, Chen, W, Shen, J, Accortt, N, Collier, D, Sauer, B ().

    SAT0078 MAJOR CHANGES IN THERAPY PRODUCE SIGNIFICANT CLINICAL IMPROVEMENT ACROSS A BROAD RANGE OF CLINICAL DISEASE ACTIVITY IN US VETERANS WITH RHEUMATOID ARTHRITIS

    [Abstract]. 78(Suppl 2), 1103.
  2. Walsh, JA, Pei, S, Penmetsa, G, Sauer, B, Pati, B, Walker, J, Clewell, J, Douglas, K, Clegg, D, Cannon, G, Halwani, A ().

    THU0629 TREATMENT PATTERNS WITH DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN UNITED STATES VETERANS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS

    [Abstract]. 78(Suppl 2), 608-610.
  3. Cannon, G, Rojas, J, Bell, N, Singh, N, Mikuls, T, Caplan, L, Kerr, G, Baker, J, Gaffo, A, Barton, J, Lazaro, D, Richards, JS, Sauer, B ().

    AB1200 IMPROVEMENT IN THE QUANTITY AND QUALITY OF OBSERVATIONAL DATA COLLECTED FOR US VETERANS ENROLLED IN THE VETERANS AFFAIRS RHEUMATOID ARTHRITIS REGISTRY USING AN ELECTRONIC AUDIT, FEEDBACK, AND DATA CORRECTION SYSTEM

    [Abstract]. 78(Suppl 2), 2061.
  4. Friedman, DR, Patil, V, Rasmussen, KM, Sauer, BC, Kelley, MJ, Halwani, AS ().

    Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience.

    [Abstract]. 37(15_suppl), e23120.
  5. Kovesdy, CP, Gosmanova, EO, Woods, SD, Fogli, JJ, Rowan, CG, Hansen, JL, Sauer, BC ().

    Emergency Department Visits and Hospitalizations in US Veterans with Hyperkalemia

    [Abstract]. 73(5), 690.
  6. Jones, BE, Ying, J, Stevens, V, He, T, Sauer, B, Bostwick, AD, Jones, M, Samore, M, Greene, T ().

    Benefit Versus Harm of Empiric Anti-MRSA Therapy in Hospitalized Patients with Pneumonia

    [Abstract]. A4224.
  7. Burningham, Z, Sauer, BC, Leng, J, Patel, S, Halwani, A, Lagha, RR, Huynh, T, Kramer, BJ ().

    The Development of the Veterans Affairs Geriatric Scholars Data Repository (GSDR) Using a Non-traditional ELT Approach.

    [Abstract].
  8. Liu, F, Pradhan, R, Druhl, E, Freund, E, Liu, W, Sauer, BC, Cunningham, F, Gordon, AJ, Peters, CB, Yu, H ().

    Learning to Detect and Understand Drug Discontinuation Events From Clinical Narratives.

    [Abstract].
  9. Gosmanova EO, Kovesdy, CP, Woods SD, Fogli J, Rowan CG, Hansen JL, Sauer BC ().

    Disparities in Real-World Utilization Patterns of Potassium Binders in US Veterans with Hyperkalemia

    [Abstract]. 46(2), 238.
  10. Stevens V, Ying J, Leecaster M, Sauer B, Rubin, M ().

    485. On- and Post-Antibiotic Effects on the Risk of Hospital-Acquired Clostridium difficile Infection (CDI)

    [Abstract]. 5(Suppl 1), S180.
  11. Halwani, A, Rasmussen, KM, Patil, V, Li, C, Young, C, Burningham, Z, Schulz, M, Li, J, Masaquel, A, Halloran, M, Delong-Sieg, E, Sauer, BC ().

    Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration

    [Abstract]. 132(1), 4205.
  12. Halwani, AS, Rasmussen, KM, Patil, V, Burningham, Z, Li, C, Young, C, Masaquel, A, Henderson, K, Delong-Sieg, E, Sauer, BC ().

    Factors Associated with Overall Survival in Follicular Lymphoma Patients Who Are Eligible for Maintenance Therapy

    [Abstract]. 132(1), 4159.
  13. Lagha, RR, Burningham, Z, Sauer, BC, Leng, J, Peters, C, Huynh, T, Patel, S, Kramer, BJ ().

    Usability Testing the Geriatric Scholars Quality Improvement Dashboards.

    [Abstract]. 2(1), 815-816.
  14. Patel, S, Sauer, BC, Burningham, Z, Chen, W, Leng, J, Huynh, T, Lagha, RR, Kramer, BJ ().

    Impact of the Geriatric Scholars Program on Prescribing Practices.

    [Abstract]. 2(1), 815.
  15. Burningham, Z, Lagha, RR, Leng, J, Peters, C, Huynh, T, Patel, S, Sauer, BC, Kramer, BJ ().

    CREATION OF A SUITE OF QUALITY IMPROVEMENT DASHBOARDS FOR THE GERIATRIC SCHOLARS PROGRAM

    [Abstract]. 2(1), 814-815.
  16. Peters, CB, Cunningham, F, Yu, H, Gordon, AJ, Zacher, J, Carico, R, Salone, C, Leng, J, Smith-Nemard, N, Liu, W, Lu, C, Druhl, E, Huynh, T, Burningham, Z, Liu, F, Sauer, BC ().

    Reference Standard Development to Train Natural Language Processing Algorithms to Detect Problematic Buprenorphine-Naloxone Therapy

    [Abstract].
  17. Burngham, Z, Richter, R, Sauer, B, Leng, J, Peters, C, Huynh, T, Patel, S, Halwani, A, Kramer, B ().

    Usability Testing a Clinical Dashboard Reporting System: Lessons Learning from the Veterans Affairs Geriatric Scholars Program.

    [Abstract].
  18. Halwani, AS, Rasmussen, K, Patil, V, Burningham, Z, Low, C, Reyes, CM, Masaquel, A, Henderson, K, Delong-Sieg, E, Sauer, BC ().

    Maintenance Rituximab After First Line Treatment in Veterans with Follicular Lymphoma Is Associated with Prolonged Overall Survival

    [Abstract]. 130(1), 1489.
  19. J Leng, CC Lu, G Cannon, CC Teng, X Zhou, T He, DJ Harrison, N Shah, BC Sauer (). Performance of NLP tool designed to identify and extract biologic drug infusion data from clinical notes [Abstract]. Value in Health, 17(3), A187-A187.
  20. CC Lu, J Leng, G Cannon, X Zhou, DJ Harrison, N Shah, BC Sauer (). Accuracy of a natural language processing software designed to compute average weekly dose from narrative medication schedule [Abstract]. Value in Health 17 (3), A187-A188, 17(3), A187-A188.
  21. Porucznik CA, Crook J, Johnson EM, Rolfs RT, Sauer BC (). Physician specialty and opioid prescribing in the Utah controlled substance database, 2005-2009 [Abstract]. American Academy of Pain Medicine.
  22. Cannon GW, Wolff RK, Ying J, Hayden CL, Sauer BC, Curtis JR, Johnson DS, Kerr GS, Richards S, Caplan L, Reimold A, Mikuls TR (). Candidate Gene Analysis in US Veteran Rheumatoid Arthritis Patients with Clinical Improvement during Treatment with Anti-Tumor Necrosis Factor Agents in the Veterans Affairs Rheumatoid Arthritis
    (VARA) Registry
    [Abstract]. Arthritis and Rheumatism, 62(10), S460.
  23. Cannon GW, Sauer BC, Hayden CL, Caplan L, Kerr GS, Richards S, Johnson DS, Mikuls TR, Reimold AM (). Clinical Response during Sequential Anti-Tumor Necrosis factor Therapy in US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) Registry [Abstract]. Arthritis and Rheumatism, 62(10), S746-S747.
  24. LaFleur J, Ghate S, Sauer B (). Updating the RxRisk-V measure: Creating a crosswalk between Veterans Affairs pharmacy codes and First Databank therapeutic categories [Abstract]. Value in Health, 11(3), A191.
  25. Ghate SR, LaFleur J, Sauer B, Charland S (). A modified RxRisk-V comorbidity index predicts adherence with lipid lowering therapy. (Poster session presented at International Society for Pharmacoeconomics and Outcomes Research 13th Annual International Meeting. Toronto, Ontario, Canada. May 2008) [Abstract]. Value In Health, 11(3), A185.
  26. Sauer BC, Winterstein AG, Mattenklotz AM (). Design and validity of automated healthcare data screens to detect in-hospital adverse drug events [Abstract]. Value in Health, 5(3), 225-226.
  27. Cannon, GW, Chen, W, Shen, J, Accortt, NA, Collier, DH, Sauer, BC ().

    Major Changes in Therapy Produce Significant Clinical Improvement Across a Broad Range of Clinical Disease Activity in US Veterans with Rheumatoid Arthritis.

    [Abstract].

Report

  1. Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Sturmer T, West SL, Schneeweiss S (). The Incident User Design in Comparative Effectiveness Research - Effective Health Care Program Research Reports (32). Rockville: Agency for Healthcare Research and Quality.
  2. Sauer BC (). Methodologic Framework to Identify Possible Adverse Drug Reaction Using Population-Based Administrative Data (Thesis). Salt Lake City: University of Utah.
  3. Porucznik CA, Sauer BC, Johnson EM, Crook J, Wrathall J, Anderson JW, Rolfs RT (). Adult Use of Prescription Opioid Pain Medications — Utah, 2008 (2010:59(6)153-157). Salt Lake City: CDC Morbidity and Mortality Weekly Report.
  4. Sauer BC, Shinogle JA, Xu W, Samore M, Nebeker J, Liu Z, Rupper R, Lux L, Amoozegar J, Lohr KN (). Improving Patient Safety and Pharmacovigilance: Methods Using Observational Data and Cohort Studies (Number 6). Agency for Healthcare Research and Quality.
  5. Sauer BC (). Medication use performance indicator evaluation: A systems perspective - A dissertation presented to the graduate school of the University of Florida in partial fulfillment of the requirements for the degree of doctor of philosophy (Dissertation). University of Florida.

Video